Elevated serum Krebs von den Lungen-6 in systemic sclerosis: a marker of lung fibrosis and severity of the disease

Objectives We aimed to assess the clinical significance of Krebs von den Lungen-6 (KL-6) in the diagnosis and severity of interstitial lung disease (ILD) in a French cohort of patients with systemic sclerosis (SSc). Methods Serum KL-6 concentrations were measured with chemiluminescent enzyme immunoa...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Rheumatology international 2018-05, Vol.38 (5), p.813-819
Hauptverfasser:	Benyamine, Audrey, Heim, Xavier, Resseguier, Noémie, Bertin, Daniel, Gomez, Carine, Ebbo, Mikaël, Harlé, Jean-Robert, Kaplanski, Gilles, Rossi, Pascal, Bardin, Nathalie, Granel, Brigitte
Format:	Artikel
Sprache:	eng
Schlagworte:	Biomarkers Immunoglobulins Life Sciences Lung diseases Medicine Medicine & Public Health Multivariate analysis Rheumatology Scleroderma Systemic sclerosis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!